Advent Life Sciences Fund II LP — Form D/A
Advent Life Sciences Fund II LP of LONDON, X0, a pooled investment fund, filed a Form D amendment with the SEC on 2014-11-03. The offering totals $226.3M, of which $226.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2014-11-03
- Form: D/A
- Accession: 0001144204-14-064575
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $226.3M
- Amount sold: $226.3M
- Investors: 15
- Date of first sale: 2014-09-09
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-224448
Issuer
- Name: Advent Life Sciences Fund II LP
- CIK: 0001614918
- Entity type: Limited Partnership
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2014
- Address: 158-160 NORTH GOWER STREET, LONDON, X0, NW1 2ND
- Phone: 44 207 932 2100
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| - Advent Life Sciences LLP | Executive Officer | London, X0 |
| Kaasim Mahmood | Executive Officer | London, X0 |
| Shahzad Malik | Executive Officer | San Diego, CA |
| Rajesh Parekh | Executive Officer | London, X0 |
| Dale Pfost | Executive Officer | LONG ISLAND CITY, NY |
| - Advent Life Sciences LLP | Promoter | London, X0 |
| - Advent LS II LP | Promoter | LONDON, X0 |
Other filings by this issuer (1)
More